Search results
-
-
Blog
30 Years of Innovation in Drug Development: The Evolution of the Contract Research Organization
Explore 30 years of CRO evolution, from preclinical roots to integrated, flexible partnerships—and how Altasciences is shaping the future of drug development.
-
-
Blog
First-in-Human-Enabling Toxicology Programs: Common Misconceptions by Grace M. Furman
Grace Furman, President and CEO of Paracelsus, explores common misconceptions in IND-enabling toxicology programs and how sound regulatory toxicology supports safe, successful FIH trials.
-
